Baird Maintains Outperform on Boston Scientific, Raises Price Target to $51
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice TargetHot
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Baird analyst David Rescott maintains Boston Scientific (NYSE:BSX) with a Outperform and raises the price target from $50 to $51.
Baird analyst David Rescott maintains Boston Scientific (NYSE:BSX) with a Outperform and raises the price target from $50 to $51.
More on BSX
Benzinga
Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 YearsBoston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 2.14% on an annualized basis producing an average annual return of 15.02%. Currently, Boston Scientific has a market…

